These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 126372)

  • 1. [Letter: Comment on therapy of Down's syndrome from the cytogenetic and clinical viewpoints].
    Pfeiffer RA
    Monatsschr Kinderheilkd (1902); 1975 Sep; 123(9):678-83. PubMed ID: 126372
    [No Abstract]   [Full Text] [Related]  

  • 2. [Letter: "Basis therapy" and especially "cell therapy" in Down's syndrome].
    Betke K; Schäfer KH
    Monatsschr Kinderheilkd (1902); 1975 Sep; 123(9):667-71. PubMed ID: 126368
    [No Abstract]   [Full Text] [Related]  

  • 3. [Letter: Comment on therapy of Down's syndrome, especially on cell therapy from the neurophysiological/neuropediatric viewpoint].
    Schulte FJ
    Monatsschr Kinderheilkd (1902); 1975 Sep; 123(9):683-5. PubMed ID: 126373
    [No Abstract]   [Full Text] [Related]  

  • 4. [Letter: Comment on fresh-cell therapy of children with special reference to Down's syndrome and other cerebral damages].
    Hitzig WH
    Monatsschr Kinderheilkd (1902); 1975 Sep; 123(9):676-8. PubMed ID: 126371
    [No Abstract]   [Full Text] [Related]  

  • 5. [Present treatment of Down's syndrome].
    Givovich L; Colombo M; Lacassie Y
    Rev Chil Pediatr; 1982; 53(5):496-502. PubMed ID: 6222437
    [No Abstract]   [Full Text] [Related]  

  • 6. [Letter: Comment on indication for fresh or sicca-cell therapy of mongolism from the pediatric-endocrinologic viewpoint].
    Bierich JR
    Monatsschr Kinderheilkd (1902); 1975 Sep; 123(9):671-4. PubMed ID: 126369
    [No Abstract]   [Full Text] [Related]  

  • 7. Review of drug treatment for Down's syndrome persons.
    Share JB
    Am J Ment Defic; 1976 Jan; 80(4):388-93. PubMed ID: 2011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of vitamin mineral supplementation in Down's syndrome.
    Smith GF; Spiker D; Peterson C; Cicchetti D; Justice P
    Lancet; 1983 Jul; 2(8340):41. PubMed ID: 6134900
    [No Abstract]   [Full Text] [Related]  

  • 9. Serotonin levels and intelligence in trisomy-21 type Down's syndrome.
    Marsh RW
    N Z Med J; 1969 Sep; 70(448):179. PubMed ID: 4242285
    [No Abstract]   [Full Text] [Related]  

  • 10. [Letter: Institutionalization of children with Down's syndrome].
    Engbaek S
    Ugeskr Laeger; 1976 Jun; 138(25):1544-5. PubMed ID: 132728
    [No Abstract]   [Full Text] [Related]  

  • 11. [Letter: Comment on cell therapy in children with special reference to pediatric-metabolic problems].
    Bremer HJ
    Monatsschr Kinderheilkd (1902); 1975 Sep; 123(9):674-5. PubMed ID: 126370
    [No Abstract]   [Full Text] [Related]  

  • 12. The feasibility of treating Down's disease with a reduced phenylalanine diet.
    Marsh RW
    N Z Med J; 1971 Aug; 74(471):116-7. PubMed ID: 4260154
    [No Abstract]   [Full Text] [Related]  

  • 13. [Siccacell therapy in Down's syndrome].
    Armoni M; Schlesinger M; Levin S
    Harefuah; 1985 Jan; 108(2):64-8. PubMed ID: 3158577
    [No Abstract]   [Full Text] [Related]  

  • 14. Myxedema coma in a patient with Down's syndrome.
    Bansal D; Nanda A; Gupta E; Croker M; Williams ML; Bacchus A; Simmons D; Erbland M
    J Ark Med Soc; 2006 Nov; 103(5):112-3. PubMed ID: 17112110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral hygiene in children with Down's syndrome.
    Pels E; Mielnik-Błaszczak M
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):442-7. PubMed ID: 12898877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiotherapy management of Down's Syndrome.
    York-Moore R
    Physiotherapy; 1976 Jan; 62(1):16-8. PubMed ID: 130643
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Improving babies with Down's syndrome.
    White G
    Med J Aust; 1974 Aug; 2(5):184. PubMed ID: 4278643
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of human fetal tissue transplantation on development of higher mental functions in children with Down's syndrome].
    Grebennikova NV; Burkova MI; Fisenko AP; Ionova NA; Molnar EM; Sukhikh GT
    Biull Eksp Biol Med; 1995 Dec; 120(12):631-5. PubMed ID: 8834220
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hormonal therapy of Down's syndrome].
    BLAIM A; SERAFINOWA R
    Pediatr Pol; 1955 Nov; 30(11):1017-30. PubMed ID: 13310056
    [No Abstract]   [Full Text] [Related]  

  • 20. Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.
    Guidi S; Stagni F; Bianchi P; Ciani E; Giacomini A; De Franceschi M; Moldrich R; Kurniawan N; Mardon K; Giuliani A; Calzà L; Bartesaghi R
    Brain; 2014 Feb; 137(Pt 2):380-401. PubMed ID: 24334313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.